OpenCitations
metadata only
Dysregulation Of JAK-STAT Pathway In Hematological Malignancies And JAK Inhibitors For Clinical Application
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- JAK inhibitor selection in challenging scenarios of myelofibrosis: a review#185375
- Nucleo-amino acid derived AMO as a potential JAK inhibitor: machine learning screening, docking, molecular dynamics, ADMET/toxicity, and MM-PBSA analysis.#330811
- A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients#1112050
- Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma#967743
- Loss of JAK1 Function Causes Radioresistance and G2/M Cell Cycle Defects Vulnerable to Kif18a Inhibition#216397
Record · ID 19603
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive